TREACE MEDICAL CONCEPTS, INC.
TMCI
DELAYED 1 MONTH

14 insider filings · Latest: Jun 10, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 11, 2026Jun 11 8:52 PMTreace John T.Director, Chief Executive Officer, 10% Owner
Purchase
22,887$4.04$92.5K7,376,150(D)

View →

Jun 10, 2026Jun 11 8:52 PMTreace John T.Director, Chief Executive Officer, 10% Owner
Purchase
29,430$4.02$118.4K7,353,263(D)

View →

Jun 1, 2026Jun 1 8:38 PMTreace John T.Director, Chief Executive Officer, 10% Owner
Purchase
50,000$3.56$177.9K7,323,833(D)

View →

May 28, 2026May 28 8:33 PMTreace John T.Director, Chief Executive Officer, 10% Owner
Purchase
61,202$3.02$184.8K7,273,833(D)

View →

May 27, 2026May 28 8:33 PMTreace John T.Director, Chief Executive Officer, 10% Owner
Purchase
49,810$2.87$143.2K7,212,631(D)

View →

May 26, 2026May 28 8:33 PMTreace John T.Director, Chief Executive Officer, 10% Owner
Purchase
4,508$2.79$12.6K7,162,821(D)

View →

May 14, 2026May 14 9:33 PMTreace John T.Director, Chief Executive Officer, 10% Owner
Purchase
61,750$2.62$161.5K7,158,313(D)

View →

May 13, 2026May 14 9:33 PMTreace John T.Director, Chief Executive Officer, 10% Owner
Purchase
49,013$2.46$120.5K7,096,563(D)

View →

May 12, 2026May 14 9:33 PMTreace John T.Director, Chief Executive Officer, 10% Owner
Purchase
43,000$2.17$93.5K7,047,550(D)

View →

Stock Options & Derivatives

No transactions found.